Phase II Proof-of-concept Study of APD421

NCT01303978 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG: APD421

Sponsor

Acacia Pharma Ltd